15th ExEx Forum – 03 April 2025 – Bern Facilitating patient access to new therapeutic products
Description
The 15th Experts Exchange Expertise (ExEx) forum will address the evolving paradigms in market access to medicinal products and medical devices, considering “Environmental, Social and Governance” (ESG) as the emerging framework for ethics and compliance. Key stakeholders will critically examine how digital and regulatory innovations are advancing patient access to new therapeutic products, in both Switzerland and the European Union.
SwAPP ExEx events place a strong emphasis on fostering practical and engaging discussions that facilitate the exchange of ideas and experiences among participants, while also supporting professional development. Attendees are encouraged to make the most of networking opportunities during the breaks, particularly at lunch and the closing cocktail reception, which provide an ideal setting for interaction over food and beverages.
Do not miss this valuable opportunity to enhance your knowledge and connect with professionals from Pharma/ Biotech/ MedTech.
Programme
| 09:30 | Welcome coffee | |
|---|---|---|
| 10:00 | Introduction | |
| Marie Gaumet, Chair of the day, Managing Director, SwAPP | ||
| 10:15 | Onboarding session – Keynote | |
| “Past, Present, and Future: A Deep Dive into Sustainability by Design in Pharma Companies” Jin Vermaat, VP, Head of Patient Safety & PV-Affiliate Management & Head of R&D Europe, Takeda Pharmaceuticals |
||
| Moderator: Christelle Robert, University Professor in Chemical Ecology, University of Bern | ||
| 11:00 | Plenary session – Environmental, Social and Governance considerations and implementation strategy | |
| “Sustainable Access to Medicines: A Non-Profit Perspective” Michael Ruffo, Market Access Lead, PATH |
||
| “Navigating Sustainability Regulations in the Pharmaceutical Value Chain” Dóra Forgács, Senior Manager, Sustainability & Climate Change, PwC Switzerland |
||
| Moderator: Christelle Robert, University Professor in Chemical Ecology, University of Bern | ||
| 12:30 | Networking lunch | |
| 14:00 | Parallel focus sessions – Market access: upcoming regulatory changes and strategic trends | |
| #1 Medicinal products: Accelerating patient access to innovative drugs | #2 Digital medical devices: Market access, adoption and reimbursement | |
| “Evolving Regulatory Challenges for Swissmedic and Collaborative Regulatory Pathways Project Orbis and Access Consortium” Simon Dalla Torre, Head of Division, Regulatory Operations & Development, Sector Marketing Authorisation and Vigilance Medicinal Products, Swissmedic |
“The Missing Building Blocks” Thomas Boillat, Senior Digital Health Product Lead, F. Hoffmann – La Roche Ltd |
|
| “The New Regulation on Health Technology Assessment (HTAR)” Lieke Kusters, Regulatory Program Management Leader, F. Hoffmann – La Roche Ltd |
“Reimbursement & Market Access for Digital Health Apps” Mayella Favre, Founder & Owner, Reimbursement Expert, F+R Services GmbH, Member of the Federal Commission MiGeL/LiMA, Federal Office of Public Health (FOPH) |
|
| Moderator: Marc Schmid, Board of Directors, SwAPP | Moderator: Daniel Delfosse, Vice Director, Head of Regulation & Innovation, Swiss Medtech | |
| 15:30 | Coffee break | |
| 16:00 | Outlook session – Playing catch-up: How Switzerland is going to innovate in digital transformation? | |
| “Applying Data Science to Advanced Biomanufacturing” Anna Fournier, Principal Data Scientist, Swiss Data Science Center (SDSC) |
||
| Round-table with: Simon Dalla Torre, Thomas Boillat, Daniel Delfosse | ||
| Moderator: Ketaki Sood, Global Human Resources Business Leader, Takeda | ||
| 16:45 | Concluding remarks | |
| Marie Gaumet, Chair of the day, Managing Director, SwAPP | ||
| 17:00 | Closing networking cocktail reception | |
Featured speakers (in order of appearance)
Jin Vermaat
Michael Ruffo
Dóra Forgács
Simon Dalla Torre
Lieke Kusters
Thomas Boillat
Mayella Favre
Anna Fournier
Moderators (in order of appearance)
Marie Gaumet
Christelle Robert
Marc Schmid
Daniel Delfosse
Ketaki Sood
Objectives and intended audience
Support Pharma/Biotech/MedTech professionals, both experienced & newcomers, in building and maintaining their network and knowledge throughout their careers with key resources. SwAPP strives to focus on Research, Development and Go-to-Market strategy for Therapeutic Products, integrating cutting-edge and digital technologies, while enhancing its commitment to ESG (Environmental, Social, and Governance).
Venue
Sorell Hotel Ador
Laupenstrasse 15, CH-3001 Bern
(7-min walk from train station)
Sorell Hotel Ador
Accreditation
This event is accredited with 4.5 credits by SwAPP
Sponsorship opportunities
Please contact us at swapp@swapp.ch «ExEx Sponsorship».
Participation fees
Registration
– Registration and payment are required prior to the event.
– Please note that by registering, you accept that your name will appear on list of participants communicated to other attendees; and you consent to SwAPP capturing photographs and videos during the event, which may be utilized in future communication and promotional materials.
– In case of cancellation, refund is only possible up to 15 business days before the event (CHF 80.- fees will apply).
– You can register from the below table and pay online. This is the fastest and recommended way to register. If you prefer to receive a bill, you can also register manually.
– For any question, contact us at swapp@swapp.ch (object “ExEx2025”).